Inhibition of early and late phase allergic reactions by Euphorbia hirta L.

Phytotherapy Research

Volumn 20, Issue 4, 2006, Pages 316-321

  Singh, G D ^a   Kaiser, P ^a   Youssouf, M S ^a   Singh, S ^a   Khajuria, A ^a   Koul, A ^a   Bani, S ^a   Kapahi, B K ^a   Satti, N K ^a   Suri, K A ^a   Johri, R K ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

Allergy; Compound 48 80; Edema; Eosinophil peroxidase; Euphorbia hirta L.; Histamine; Immunosuppression; Interferon , eosinophils; Interleukin 4; Peritoneal mast cells

Indexed keywords

ALCOHOL; CD4 ANTIGEN; CD8 ANTIGEN; CETIRIZINE; CYCLOPHOSPHAMIDE; DEXTRAN; EOSINOPHIL PEROXIDASE; EUPHORBIA EXTRACT; GAMMA INTERFERON; INTERLEUKIN 4; KETOTIFEN; OVALBUMIN;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; DEGRANULATION; DRUG ACTIVITY; DRUG INHIBITION; EDEMA; EOSINOPHIL; EUPHORBIA; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PERITONEUM MAST CELL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; RAT; SPLEEN CELL;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CD4-CD8 RATIO; CYTOKINES; EDEMA; EOSINOPHIL PEROXIDASE; EOSINOPHILS; EUPHORBIA; HISTAMINE ANTAGONISTS; HYPERSENSITIVITY; LEUKOCYTE COUNT; MALE; MICE; MICE, INBRED BALB C; OVALBUMIN; PLANT EXTRACTS; RATS; RATS, WISTAR; SPLEEN;

ANIMALIA; CHAMAESYCE HIRTA; EUPHORBIA;

EID: 33645926339     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.1844     Document Type: Article

References (27)

1. Cui T, Kusunose M, Hamada A et al. 2003. Relationship between the eosinophilia of bronchoalveolar lavage fluid (BALF) and the severity of pulmonary fibrosis induced by bleomycin in rats. Biol Pharm Bull 26: 959-963.
2. Dai Y, Chan YP, Chu, LM, But LP. 2002. Antiallergic and anti-inflammatory properties of ethanolic extract from Gleditsia sinensis. Biol Pharm Bull 25: 1179-1182.
3. Fitzpatrick L, Kaiser M, Stewart BH, Hoskin DW. 1994. Effect of interferon-gamma, interleukin-2 and interleukin-4 on cyclosporin A-mediated inhibition of anti-CD3-induced T-lymphocyte proliferation. Int J Immunopharmacol 16: 289-293.
4. Galvez J, Zarzeulo A, Crespo ME et al. 1992. Anti-diarrhoeic activity of Euphorbia hirta extract and isolation of an active flavanoid constituent. Planta Med 59: 333-336.
5. Glimcher LH, Murphy KM. 2000. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev 14: 1693-1711.
6. Gupta M, Mazumdar UK, Sivakumar T et al. 2003. Evaluation of anti-inflammatory activity of chloroform extract of Bryonia lacinosa in experimental animal models. Biol Pharm Bull 26: 1342-1344.
7. Hiermann A, Bucar F. 1994. Influence of some traditional medicinal plants of Senegal on prostaglandin biosynthesis. J Ethnopharmacol 42: 111-116.
8. Herz U, Lumpp U, Da Palma JC et al. 1996. 1996. The relevance of murine animal models to study the development of allergic bronchial asthma. Immunol Cell Biol 74: 209-217.
9. Hoshino M, Nakamura Y, Shin Z, Fukushima Y. 1997. Effect of ketotifen on symptoms of bronchial mucosa in patients with atopic asthma. Allergy 52: 814-820.
10. Johnson PB, Abdurahman EM, Tiam EA et al. 1999. Euphorbia hirta leaf extracts increase urine output and electrolytes in rats. J Ethnopharmacol 65: 63-69.
11. Kaul A, Bani S, Zutshi U et al. 2003. Immunopotentiating properties of Cryptolepis buchanani root extract. Phytother Res 17: 1140-1144.
12. Lanhers MC, Fleurentin J, Cabalion P et al. 1990. Behavioural effects of Euphorbia hirta L.: sedative and anxiolytic properties. J Ethnopharmacol 29: 189-198.
13. Lanhers MC, Fleurentin J, Dorfman P et al. 1991. Analgesic, antipyretic and anti inflammatory properties of Euphorbia hirta. Planta Med 57: 225-231.
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with Folin phenol reagent. J Biol Chem 193: 263-270.
15. Mhaskar KS, Blatter E, Caius JF (eds). 2000. Kiritikar & Basu's Illustrated Indian Medicinal Plants, Satguru Publications, New Delhi, volume 9: 3031-3033.
16. Mousli M, Bronner C, Landry Y et al. 1990. Direct activation of GTP binding regulatory proteins (G proteins) by substance P and compound 48/80. FEBS Lett 259: 260-262.
17. Portnoy JM, Dinakar C. 2004. Review of cetirizine hydrochloride for the treatment of allergic disorders. Expert Opin Pharmacother 5: 125-135.
18. Romagnani S. 2003. New therapeutic strategies in allergic diseases. Drugs Today 39: 849-865.
19. 2 cell type airway immune responses in a mild but not in more severe asthma model. Eur J Immunol 33: 991-1000.
20. Shastri BN. 1952. Wealth of India. A Dictionary of Indian Raw Materials and Industrial Products. Raw Materials. Council of Scientific and Industrial Research: New Delhi, III: 225.
21. Shin T-Y. 2004. Strachys riederi inhibits mast cell-mediated acute and chronic allergic reactions. Immunopharmacol Immunotoxicol 26: 621-630.
22. Shin TY, Lee JK. 2003. Effect of Phlomis umbrosa root on mast cell dependent immediate type allergic reactions by anal therapy. Immunopharmacol Immunotoxicol 25: 73-85.
23. Shore PA, Burkhalter A, Conn VHA. 1959. A method for the fluorimetric assay of histamine in tissues. J Pharmacol Exp Ther 127: 182-186.
24. Sulkowski S, Sulkowska M, Musiatowicz B. 1998. The effects of cyclophosphamide on pulmonary thrombopoiesis in rats. Histol Histopathol 13: 1027-1036.
25. Trifilieff A, Wyss D, Walker C et al. 2002. Pharmacological profile of a novel phosphodiesterase-4 inhibitor, 4-(8-benzo[1,2,5]oxadiazol-5-yl-[1,7] napthyridin-6-yl) benzoic acid (NVP-ABE 171), a 1,7- napthyridine derivative, with anti inflammatory activities. J Pharmacol Exp Ther 301: 241-248.
26. Vijaya K, Ananthan S, Nalini R. 1995. Antibacterial effect of theaflavin, polyphenon 60 (Camellia sinensis) and Euphorbia hirta on Shigella spp. - a cell culture study. J Ethnopharmacol 49: 115-118.
27. Whitney KC, Anderson C, Duplantier A et al. 2002. Pulmonary eosinophilia in a murine model of allergic inflammation is attenuated by small molecule α4β1 antagonists. J Pharmacol Exp Ther 301: 714-752.